Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

October 01, 1995; Volume 23,Issue 10
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Benet, L Z

    1. You have access
      Stereoselective disposition of naproxen glucuronide in the rat.
      M Iwaki, A Bischer, A C Nguyen, A F McDonagh and L Z Benet
      Drug Metabolism and Disposition October 1995, 23 (10) 1099-1103;
  2. Bergeron, R J

    1. You have access
      Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
  3. Bhargava, R

    1. You have access
      Liver volume as a determinant of drug clearance in children and adolescents.
      D J Murry, W R Crom, W E Reddick, R Bhargava and W E Evans
      Drug Metabolism and Disposition October 1995, 23 (10) 1110-1116;
  4. Bischer, A

    1. You have access
      Stereoselective disposition of naproxen glucuronide in the rat.
      M Iwaki, A Bischer, A C Nguyen, A F McDonagh and L Z Benet
      Drug Metabolism and Disposition October 1995, 23 (10) 1099-1103;
  5. Bugelski, P J

    1. You have access
      Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.
      T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J Bugelski
      Drug Metabolism and Disposition October 1995, 23 (10) 1044-1050;

C

  1. Carbonaro, M A

    1. You have access
      Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.
      T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J Bugelski
      Drug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
  2. Cashman, J R

    1. You have access
      In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.
      A D Rodrigues, M J Kukulka, J L Ferrero and J R Cashman
      Drug Metabolism and Disposition October 1995, 23 (10) 1143-1152;
  3. Castle, P J

    1. You have access
      Human liver lauric acid hydroxylase activities.
      P J Castle, J L Merdink, J R Okita, S A Wrighton and R T Okita
      Drug Metabolism and Disposition October 1995, 23 (10) 1037-1043;
  4. Chiu, S H

    1. You have access
      Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
      S W Huskey, D C Dean, R R Miller, G H Rasmusson and S H Chiu
      Drug Metabolism and Disposition October 1995, 23 (10) 1126-1135;
  5. Coassolo, P

    1. You have access
      Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
      B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R Rahmani
      Drug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
  6. Crom, W R

    1. You have access
      Liver volume as a determinant of drug clearance in children and adolescents.
      D J Murry, W R Crom, W E Reddick, R Bhargava and W E Evans
      Drug Metabolism and Disposition October 1995, 23 (10) 1110-1116;
  7. Crooks, P A

    1. You have access
      Determination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine.
      P A Crooks, M Li and L P Dwoskin
      Drug Metabolism and Disposition October 1995, 23 (10) 1175-1177;

D

  1. Davies, M I

    1. You have access
      Microdialysis sampling for hepatic metabolism studies. Impact of microdialysis probe design and implantation technique on liver tissue.
      M I Davies and C E Lunte
      Drug Metabolism and Disposition October 1995, 23 (10) 1072-1079;
  2. Davis, C B

    1. You have access
      Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.
      C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R Rhodes
      Drug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
    2. You have access
      Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.
      T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J Bugelski
      Drug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
  3. Dean, D C

    1. You have access
      Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
      S W Huskey, D C Dean, R R Miller, G H Rasmusson and S H Chiu
      Drug Metabolism and Disposition October 1995, 23 (10) 1126-1135;
  4. Demuth, S G

    1. You have access
      Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.
      C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R Rhodes
      Drug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
  5. De Sousa, G

    1. You have access
      Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
      B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R Rahmani
      Drug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
  6. Dimova, H

    1. You have access
      Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
  7. Dwoskin, L P

    1. You have access
      Determination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine.
      P A Crooks, M Li and L P Dwoskin
      Drug Metabolism and Disposition October 1995, 23 (10) 1175-1177;

E

  1. Endo, T

    1. You have access
      Interindividual variation in carboxylesterase levels in human liver microsomes.
      M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T Satoh
      Drug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
  2. Evans, W E

    1. You have access
      Liver volume as a determinant of drug clearance in children and adolescents.
      D J Murry, W R Crom, W E Reddick, R Bhargava and W E Evans
      Drug Metabolism and Disposition October 1995, 23 (10) 1110-1116;

F

  1. Faiman, M D

    1. You have access
      Identification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram.
      A Madan, A Parkinson and M D Faiman
      Drug Metabolism and Disposition October 1995, 23 (10) 1153-1162;
  2. Ferrero, J L

    1. You have access
      In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.
      A D Rodrigues, M J Kukulka, J L Ferrero and J R Cashman
      Drug Metabolism and Disposition October 1995, 23 (10) 1143-1152;
    2. You have access
      Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.
      J M Machinist, M D Mayer, M S Shet, J L Ferrero and A D Rodrigues
      Drug Metabolism and Disposition October 1995, 23 (10) 1163-1174;
  3. Fredenburg, A M

    1. You have access
      Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.
      R A Yokel, A M Fredenburg, K A Meurer and T L Skinner
      Drug Metabolism and Disposition October 1995, 23 (10) 1178-1180;
  4. Fujisawa, M

    1. You have access
      Interindividual variation in carboxylesterase levels in human liver microsomes.
      M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T Satoh
      Drug Metabolism and Disposition October 1995, 23 (10) 1022-1027;

G

  1. Gupta, N

    1. You have access
      Verlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.
      D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A Yergey
      Drug Metabolism and Disposition October 1995, 23 (10) 1085-1093;

H

  1. Hara, S

    1. You have access
      Interindividual variation in carboxylesterase levels in human liver microsomes.
      M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T Satoh
      Drug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
  2. Hart, T K

    1. You have access
      Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.
      C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R Rhodes
      Drug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
  3. Hepburn, T W

    1. You have access
      Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.
      C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R Rhodes
      Drug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
    2. You have access
      Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.
      T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J Bugelski
      Drug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
  4. Herzyk, D J

    1. You have access
      Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.
      C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R Rhodes
      Drug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
  5. Hosokawa, M

    1. You have access
      Interindividual variation in carboxylesterase levels in human liver microsomes.
      M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T Satoh
      Drug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
  6. Huskey, S W

    1. You have access
      Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
      S W Huskey, D C Dean, R R Miller, G H Rasmusson and S H Chiu
      Drug Metabolism and Disposition October 1995, 23 (10) 1126-1135;

I

  1. Iwaki, M

    1. You have access
      Stereoselective disposition of naproxen glucuronide in the rat.
      M Iwaki, A Bischer, A C Nguyen, A F McDonagh and L Z Benet
      Drug Metabolism and Disposition October 1995, 23 (10) 1099-1103;
  2. Iwata, N

    1. You have access
      Interindividual variation in carboxylesterase levels in human liver microsomes.
      M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T Satoh
      Drug Metabolism and Disposition October 1995, 23 (10) 1022-1027;

J

  1. Jaeck, D

    1. You have access
      Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
      B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R Rahmani
      Drug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
  2. Juchau, M R

    1. You have access
      Xenopus laevis: a model system for the study of embryonic retinoid metabolism. III. Isomerization and metabolism of all-trans-retinoic acid and 9-cis-retinoic acid and their dysmorphogenic effects in embryos during neurulation.
      J C Kraft and M R Juchau
      Drug Metabolism and Disposition October 1995, 23 (10) 1058-1071;

K

  1. Kleiner, H E

    1. You have access
      Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.
      S S Lau, H E Kleiner and T J Monks
      Drug Metabolism and Disposition October 1995, 23 (10) 1136-1142;
  2. Kraft, J C

    1. You have access
      Xenopus laevis: a model system for the study of embryonic retinoid metabolism. III. Isomerization and metabolism of all-trans-retinoic acid and 9-cis-retinoic acid and their dysmorphogenic effects in embryos during neurulation.
      J C Kraft and M R Juchau
      Drug Metabolism and Disposition October 1995, 23 (10) 1058-1071;
  3. Kukulka, M J

    1. You have access
      In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.
      A D Rodrigues, M J Kukulka, J L Ferrero and J R Cashman
      Drug Metabolism and Disposition October 1995, 23 (10) 1143-1152;
  4. Kwok, D C

    1. You have access
      Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.
      C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R Rhodes
      Drug Metabolism and Disposition October 1995, 23 (10) 1028-1036;

L

  1. Lau, S S

    1. You have access
      Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.
      S S Lau, H E Kleiner and T J Monks
      Drug Metabolism and Disposition October 1995, 23 (10) 1136-1142;
  2. Leland, M

    1. You have access
      Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.
      C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R Rhodes
      Drug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
  3. Li, M

    1. You have access
      Determination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine.
      P A Crooks, M Li and L P Dwoskin
      Drug Metabolism and Disposition October 1995, 23 (10) 1175-1177;
  4. Lin, J H

    1. You have access
      Species similarities and differences in pharmacokinetics.
      J H Lin
      Drug Metabolism and Disposition October 1995, 23 (10) 1008-1021;
  5. Luchetta, G

    1. You have access
      Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
  6. Lunte, C E

    1. You have access
      Microdialysis sampling for hepatic metabolism studies. Impact of microdialysis probe design and implantation technique on liver tissue.
      M I Davies and C E Lunte
      Drug Metabolism and Disposition October 1995, 23 (10) 1072-1079;

M

  1. Machinist, J M

    1. You have access
      Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.
      J M Machinist, M D Mayer, M S Shet, J L Ferrero and A D Rodrigues
      Drug Metabolism and Disposition October 1995, 23 (10) 1163-1174;
  2. Madan, A

    1. You have access
      Identification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram.
      A Madan, A Parkinson and M D Faiman
      Drug Metabolism and Disposition October 1995, 23 (10) 1153-1162;
  3. Mayer, M D

    1. You have access
      Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.
      J M Machinist, M D Mayer, M S Shet, J L Ferrero and A D Rodrigues
      Drug Metabolism and Disposition October 1995, 23 (10) 1163-1174;
  4. McDonagh, A F

    1. You have access
      Stereoselective disposition of naproxen glucuronide in the rat.
      M Iwaki, A Bischer, A C Nguyen, A F McDonagh and L Z Benet
      Drug Metabolism and Disposition October 1995, 23 (10) 1099-1103;
  5. Merdink, J L

    1. You have access
      Human liver lauric acid hydroxylase activities.
      P J Castle, J L Merdink, J R Okita, S A Wrighton and R T Okita
      Drug Metabolism and Disposition October 1995, 23 (10) 1037-1043;
  6. Meurer, K A

    1. You have access
      Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.
      R A Yokel, A M Fredenburg, K A Meurer and T L Skinner
      Drug Metabolism and Disposition October 1995, 23 (10) 1178-1180;
  7. Miller, R R

    1. You have access
      Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
      S W Huskey, D C Dean, R R Miller, G H Rasmusson and S H Chiu
      Drug Metabolism and Disposition October 1995, 23 (10) 1126-1135;
  8. Monks, T J

    1. You have access
      Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.
      S S Lau, H E Kleiner and T J Monks
      Drug Metabolism and Disposition October 1995, 23 (10) 1136-1142;
  9. Murry, D J

    1. You have access
      Liver volume as a determinant of drug clearance in children and adolescents.
      D J Murry, W R Crom, W E Reddick, R Bhargava and W E Evans
      Drug Metabolism and Disposition October 1995, 23 (10) 1110-1116;

N

  1. Nguyen, A C

    1. You have access
      Stereoselective disposition of naproxen glucuronide in the rat.
      M Iwaki, A Bischer, A C Nguyen, A F McDonagh and L Z Benet
      Drug Metabolism and Disposition October 1995, 23 (10) 1099-1103;
  2. Nicoll-Griffith, D A

    1. You have access
      Verlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.
      D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A Yergey
      Drug Metabolism and Disposition October 1995, 23 (10) 1085-1093;

O

  1. Okita, J R

    1. You have access
      Human liver lauric acid hydroxylase activities.
      P J Castle, J L Merdink, J R Okita, S A Wrighton and R T Okita
      Drug Metabolism and Disposition October 1995, 23 (10) 1037-1043;
  2. Okita, R T

    1. You have access
      Human liver lauric acid hydroxylase activities.
      P J Castle, J L Merdink, J R Okita, S A Wrighton and R T Okita
      Drug Metabolism and Disposition October 1995, 23 (10) 1037-1043;

P

  1. Parkinson, A

    1. You have access
      Identification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram.
      A Madan, A Parkinson and M D Faiman
      Drug Metabolism and Disposition October 1995, 23 (10) 1153-1162;
  2. Perrin, J

    1. You have access
      Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
  3. Porter, C

    1. You have access
      Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;

R

  1. Rahmani, R

    1. You have access
      Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
      B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R Rahmani
      Drug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
  2. Rasmusson, G H

    1. You have access
      Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
      S W Huskey, D C Dean, R R Miller, G H Rasmusson and S H Chiu
      Drug Metabolism and Disposition October 1995, 23 (10) 1126-1135;
  3. Reddick, W E

    1. You have access
      Liver volume as a determinant of drug clearance in children and adolescents.
      D J Murry, W R Crom, W E Reddick, R Bhargava and W E Evans
      Drug Metabolism and Disposition October 1995, 23 (10) 1110-1116;
  4. Rhodes, G R

    1. You have access
      Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.
      C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R Rhodes
      Drug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
  5. Rodrigues, A D

    1. You have access
      In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.
      A D Rodrigues, M J Kukulka, J L Ferrero and J R Cashman
      Drug Metabolism and Disposition October 1995, 23 (10) 1143-1152;
    2. You have access
      Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.
      J M Machinist, M D Mayer, M S Shet, J L Ferrero and A D Rodrigues
      Drug Metabolism and Disposition October 1995, 23 (10) 1163-1174;

S

  1. Sanders, R A

    1. You have access
      Minimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits.
      S G Sastry, R A Sanders, J C Veltman and J B Watkins
      Drug Metabolism and Disposition October 1995, 23 (10) 1094-1098;
  2. Sastry, S G

    1. You have access
      Minimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits.
      S G Sastry, R A Sanders, J C Veltman and J B Watkins
      Drug Metabolism and Disposition October 1995, 23 (10) 1094-1098;
  3. Sato, Y

    1. You have access
      Interindividual variation in carboxylesterase levels in human liver microsomes.
      M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T Satoh
      Drug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
  4. Satoh, T

    1. You have access
      Interindividual variation in carboxylesterase levels in human liver microsomes.
      M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T Satoh
      Drug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
  5. Schaefer, W H

    1. You have access
      Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.
      T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J Bugelski
      Drug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
  6. Schiller, C D

    1. You have access
      Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
      B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R Rahmani
      Drug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
  7. Schreier, K M

    1. You have access
      Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
  8. Shet, M S

    1. You have access
      Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.
      J M Machinist, M D Mayer, M S Shet, J L Ferrero and A D Rodrigues
      Drug Metabolism and Disposition October 1995, 23 (10) 1163-1174;
  9. Skinner, T L

    1. You have access
      Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.
      R A Yokel, A M Fredenburg, K A Meurer and T L Skinner
      Drug Metabolism and Disposition October 1995, 23 (10) 1178-1180;
  10. Sladek, N E

    1. You have access
      Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.
      L Sreerama and N E Sladek
      Drug Metabolism and Disposition October 1995, 23 (10) 1080-1084;
  11. Smith, B R

    1. You have access
      Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.
      T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J Bugelski
      Drug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
  12. Sreerama, L

    1. You have access
      Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.
      L Sreerama and N E Sladek
      Drug Metabolism and Disposition October 1995, 23 (10) 1080-1084;
  13. Streiff, R R

    1. You have access
      Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;

T

  1. Trimble, L A

    1. You have access
      Verlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.
      D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A Yergey
      Drug Metabolism and Disposition October 1995, 23 (10) 1085-1093;
  2. Twa, S P

    1. You have access
      Verlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.
      D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A Yergey
      Drug Metabolism and Disposition October 1995, 23 (10) 1085-1093;

U

  1. Urbanski, J J

    1. You have access
      Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.
      C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R Rhodes
      Drug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
    2. You have access
      Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.
      T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J Bugelski
      Drug Metabolism and Disposition October 1995, 23 (10) 1044-1050;

V

  1. Valles, B

    1. You have access
      Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
      B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R Rahmani
      Drug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
  2. Veltman, J C

    1. You have access
      Minimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits.
      S G Sastry, R A Sanders, J C Veltman and J B Watkins
      Drug Metabolism and Disposition October 1995, 23 (10) 1094-1098;
  3. Vickers, S

    1. You have access
      Use of gender and oxygenation as synonyms for sex and oxidation.
      S Vickers
      Drug Metabolism and Disposition October 1995, 23 (10) 1007;
  4. Viger-Chougnet, A

    1. You have access
      Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
      B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R Rahmani
      Drug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
  5. Vyas, K P

    1. You have access
      Disposition of DMP 811 (L-708,404), a potent angiotensin II receptor antagonist, in the rat, monkey, and chimpanzee.
      K E Zhang and K P Vyas
      Drug Metabolism and Disposition October 1995, 23 (10) 1104-1109;

W

  1. Watkins, J B

    1. You have access
      Minimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits.
      S G Sastry, R A Sanders, J C Veltman and J B Watkins
      Drug Metabolism and Disposition October 1995, 23 (10) 1094-1098;
  2. Weimar, W R

    1. You have access
      Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
  3. Wiegand, J

    1. You have access
      Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
  4. Williams, H

    1. You have access
      Verlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.
      D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A Yergey
      Drug Metabolism and Disposition October 1995, 23 (10) 1085-1093;
  5. Wrighton, S A

    1. You have access
      Human liver lauric acid hydroxylase activities.
      P J Castle, J L Merdink, J R Okita, S A Wrighton and R T Okita
      Drug Metabolism and Disposition October 1995, 23 (10) 1037-1043;
  6. Wyss, R

    1. You have access
      Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
      B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R Rahmani
      Drug Metabolism and Disposition October 1995, 23 (10) 1051-1057;

Y

  1. Yao, G W

    1. You have access
      Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
  2. Yergey, J A

    1. You have access
      Verlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.
      D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A Yergey
      Drug Metabolism and Disposition October 1995, 23 (10) 1085-1093;
  3. Yokel, R A

    1. You have access
      Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.
      R A Yokel, A M Fredenburg, K A Meurer and T L Skinner
      Drug Metabolism and Disposition October 1995, 23 (10) 1178-1180;

Z

  1. Zhang, K E

    1. You have access
      Disposition of DMP 811 (L-708,404), a potent angiotensin II receptor antagonist, in the rat, monkey, and chimpanzee.
      K E Zhang and K P Vyas
      Drug Metabolism and Disposition October 1995, 23 (10) 1104-1109;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 23, Issue 10
1 Oct 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Metabolism and Disposition of Volanesorsen across Species
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics